The first report of acute respiratory distress syndrome (ARDS) 
Definition

The first description of acute respiratory distress syndrome (ARDS) appeared in 1967, in a paper by Ashbaugh et al which described 12 patients with acute respiratory distress, cyanosis refractory to oxygen therapy, decrease lung compliance, and diffuse infiltrates on chest radiography (1). In 1988, an expanded definition was proposed based on the level of positive end-expiratory pressure (PEEP), the ratio of the partial pressure of arterial oxygen to the fraction of inspired oxygen, the static lung compliance, and the degree of infiltration evident on chest radiography (2). Another measurement, the lung injury score (3), has been widely used to quantify the disease severity in clinical trials, although it has not been shown to accurately predict outcome during the first 24 to 72 hours after the onset of ARDS (4). In 1994, a new definition was recommended by the American-European
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Incidence and Outcome
ALI and ARDS are severe forms of diffuse lung disease that impose a substantial health burden in the United States each year. Data from several population-based studies reveals a fairly consistent picture for the age, mortality, severity of illness, ratio of ARDS to ALI, and ratio of ALI to acute respiratory failure, yet there is almost a four-fold difference in the reported incidence of ALI/ARDS between
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moved by diffusion between alveolar epithelial cells. Insoluble protein is thought to be removed by endocytosis and transcytosis by alveolar epithelial cells and phagocytosis by alveolar macrophages (13). Type II alveolar epithelial cells proliferate to cover the injured basement membrane and differentiate into the type I alveolar epithelial cells. Apoptosis is thought to be a major mechanism for the clearance of neutrophils from the injured lung (14).
Clinical Evidence
High PEEP (15) , alveolar recruitment maneuvers, highfrequency oscillatory ventilation (HFOV) (16, 17) and prone positioning (18, 19) T a b l e 2 . B a s e -l i n e Ch a r a c t e r i s t i c s o f t h e P a t i e n t s * ( N E n g l J Me d 3 4 2 : 1 3 0 1 -1 3 0 8 , 2 0 0 0 * Plus-minus values are mean±SD. The number of ventilator-free days is the mean number of days from days from day 1 to day 28 on which the patient had been breathing without assistance for at least 48 consecutive hours. Barotrauma was defined as any new pneumothorax, pneumomediastinum, or subcutaneous emphysema, or a pneumotocele that was more than 2 cm in diameter. (27) (Fig. 3 ). There were no significant differences in mortality rates between two groups. The Plus-minus values are mean±SD.CNS, central nervous system. For this analysis, cardiovascular failure was defined by a systolic blood pressure of 90mmHg or less or the need for a vasopressor (in contrast, shock was defined by a mean arterial pressure of less than 60mmHg or the need for a vasopressor [except a dose of dopamine of 5µg/kg/minute or less]; a coagulation abnormality was defined by a platelet count of 80000/mm 3 or less; hepatic failure was defined by a serum bilirubin level of a t least 2mg/dL; and renal failure was defined by a serum creatinine levels of at least 2mg/dL. We calculated the number of days without organ or system failure by subtracting the number of days with organ failure from the lesser of 28 days or the number of days to death. (Table 5) .
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correlates with severity of illness and mortality rate (23). Meduri and Chrousor proposed that the failure of endogenous GC to suppress inflammation could be due to tissue resistance, or inadequacy of the level and duration of endogenous GC elevation to suppress a host immune response, or a combination of these two factors (24). Glucocorticoid receptor (GR)-mediated resistance in the presence of systemic inflammation has been studied in experimental models of sepsis and sepsis-induced ARDS (25); the findings suggest that increased levels of exogenous steroids are necessary to activate GR in the setting of systemic inflammation. The patients with ALI/ARDS had persistent elevations in plasma levels of inflammatory cytokines (TNF-α IL-1β and IL-6) and hypothalamic-pituitary-adrenal axis hormones and similar severity of organ dysfunction scores (26). Meduri et al hypothesized that inadequate secretion of cortisol and/or immune tissue resistance to endogenous GCs might explain the observed failure of GR to suppress inflammation in the presence of persistently elevated ACTH and cortisol levels, and they reported that prolonged methylprednisolone administration (2 mg/kg/day) initiated in a patient who had not improved after the onset of ARDS was associated with rapid, progressive, and sustained reductions in plasma and BAL inflammatory cytokines, chemokines, and procollagen levels with parallel significant improvement in lung injury and multiple organ dysfunction syndrome (26). In a randomized, controlled trial by Meduri and colleagues
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methylprednisolone-treated patients had a significantly lower rate of infection, however it was notable that among the 27 infections which developed after day
These results were similar to the conclusions of Mitchell et al (40) , who conducted a randomized controlled trial contrasting liberal and conservative approaches using pulmonary artery occlusion pressure as a guide, and despite an improvement in ventilator-free days, there was again no mortality benefit in the conservative fluid group.
Conclusion
The only intervention to achieve mortality benefit has been low-tidal volume ventilation, using a goal tidal volume of 6 
